Complete Wegovy vs Mounjaro Cost Breakdown
Understanding Wegovy vs Mounjaro Cost for Prescription Weight Loss
When comparing Wegovy vs Mounjaro cost, it's essential to understand that both are prescription-only medicines designed for long-term weight management alongside a reduced-calorie diet and increased physical activity. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro contains tirzepatide, a dual receptor agonist targeting both GLP-1 and GIP pathways. The cost differences reflect not only the medications themselves but also their distinct dosing schedules and treatment protocols.
The Wegovy vs Mounjaro cost comparison becomes particularly relevant when considering treatment duration and maintenance phases. Wegovy follows a structured 20-week dose escalation from 0.25mg to 2.4mg maintenance, with clear pricing at each stage. Mounjaro follows a different escalation pattern with its own cost structure. Both treatments represent significant investments in your health, but understanding the specific costs helps you plan your weight management journey effectively. At EverydayMeds, we provide transparent pricing for both options, allowing you to make an informed choice based on clinical suitability and budget considerations.
Detailed Wegovy vs Mounjaro Cost Pricing Structure
Wegovy pricing at EverydayMeds follows a transparent structure: 0.25mg starter dose costs £79.99, 0.5mg costs £94.99, 1mg costs £99.99, 1.7mg costs £139.99, and the maintenance 2.4mg dose costs £209.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these prices. Bundle options provide convenience rather than savings, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99, ensuring consistent supply without frequent reordering.
When evaluating Wegovy vs Mounjaro cost over a 12-month period, consider that Wegovy reaches its maintenance dose of 2.4mg at week 17, with ongoing monthly costs of £209.99 per pen thereafter. The dose escalation phase involves lower costs initially, making the treatment accessible during the adjustment period. Bundle pricing offers practical advantages for maintaining consistent treatment, particularly important given that weight management requires long-term commitment. Both treatments are available through our GPhC-registered pharmacy (#9012878), with clinical assessment ensuring you receive the most appropriate option for your circumstances.
Clinical Evidence Behind Wegovy vs Mounjaro Cost Effectiveness
The Wegovy vs Mounjaro cost evaluation must consider clinical outcomes from their respective trials. In the STEP trials, patients taking Wegovy alongside diet and exercise experienced average weight loss of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of 15.2% at 2 years, whilst the SELECT trial showed a 20% reduction in major cardiovascular events.
Mounjaro's clinical data comes from the SURMOUNT trials, showing different efficacy profiles with its dual mechanism approach. However, direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both treatments require long-term commitment, as STEP 1 extension data showed patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents an ongoing investment rather than a short-term cost.
How Wegovy Works in Weight Management
Understanding the mechanism behind Wegovy helps justify its position in the Wegovy vs Mounjaro cost comparison. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestines. This medication works by slowing gastric emptying, which means food stays in your stomach longer, promoting feelings of fullness after smaller meals. It also acts on appetite centres in the brain, potentially reducing food cravings and the psychological drive to eat. The once-weekly injection provides consistent hormone levels, supporting sustainable appetite control throughout your treatment. These mechanisms make Wegovy particularly effective for people who struggle with portion control and frequent hunger, addressing the physiological aspects of weight management that diet and exercise alone may not fully control.
Streamlined Ordering Process for Weight Loss Treatment
Accessing either option in the Wegovy vs Mounjaro cost comparison begins with our 3-minute online clinical assessment, designed to evaluate your medical history, current medications, and weight management goals. Once submitted, your assessment undergoes prescriber review within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before dispensing any prescription-only medicine. Upon approval, your medication ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication stability. Our GPhC-registered pharmacy (#9012878) ensures all prescribing and dispensing meets UK regulatory standards. The process includes comprehensive patient information and injection training materials, supporting successful treatment initiation regardless of which option proves most suitable for your circumstances.
Storage and Practical Considerations in Treatment Costs
Practical factors significantly impact the true Wegovy vs Mounjaro cost comparison beyond purchase price alone. Wegovy pens require refrigeration at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge, offering superior travel flexibility compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design provides precise dose delivery with audible and tactile injection confirmation, reducing waste from dosing errors. Wegovy's structured dose escalation from 0.25mg to 2.4mg over 20 weeks allows your body to adjust gradually, potentially reducing side effects that might interrupt treatment and require restart costs. Each pen contains four weekly doses, making monthly ordering convenient for ongoing treatment. These practical advantages contribute to treatment adherence, which ultimately affects the cost-effectiveness of your weight management investment.
Prescription Weight Loss Investment Planning
The Wegovy vs Mounjaro cost analysis extends beyond immediate pricing to long-term treatment planning for sustainable weight management. Wegovy's established dose escalation protocol provides predictable monthly costs once you reach maintenance dosing, allowing accurate budgeting for your health investment. The NICE TA875 recommendation supports Wegovy's position as a clinically appropriate intervention for eligible patients, potentially influencing future NHS availability considerations.
Both treatments require ongoing commitment, as clinical evidence demonstrates that weight management benefits are maintained only with continued treatment. Planning for this long-term investment involves considering not just monthly medication costs but also the broader health economic benefits of sustained weight loss, including potential reductions in obesity-related comorbidities. EverydayMeds' bundle options support treatment continuity planning, whilst our clinical team remains available to discuss treatment progression and any cost-related concerns throughout your weight management journey.
Making Your Treatment Choice
Ultimately, the Wegovy vs Mounjaro cost decision should balance financial considerations with clinical appropriateness and personal preferences. Both are prescription-only medicines available through EverydayMeds, with our clinical team helping determine which option best suits your medical history and weight management goals. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing. Our commitment to transparent pricing, clinical excellence through GPhC registration (#9012878), and comprehensive patient support ensures you receive optimal value from your prescription weight loss investment. Begin with our 3-minute assessment at https://everydaymeds.co.uk/collections/wegovy to explore your options and take the first step towards sustainable weight management with professional medical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
